Merck board rescinds policy requiring chief executive to step down at 65

Alia Paavola - Print  | 

Merck CEO Kenneth Frazier will remain at the helm of the pharmaceutical company after its board of directors rescinded a policy that required the chief executive to retire at the age of 65, according to The Wall Street Journal.

The mandatory retirement policy would have required Mr. Frazier to step down in December 2019, which is when he will turn 65.  Now, with the policy scrapped, he plans to stay as CEO beyond that date.

"CEO succession has been our top priority and removing the mandatory retirement policy enables the board to make the best decision concerning the timing of that transition," the lead board director Leslie Brun told the WSJ.

Mr. Frazier, who started at Merck in 1992, was appointed CEO and chairman in 2011.

More articles on pharmacy:
PBM lobby selects new chief with government ties: 5 things to know
AbbVie hit with lawsuit over alleged $1.2B kickback scheme
Reputation save: Novartis links employee bonuses to ethical behavior

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.